Dr. Rana Quraishi has a Ph.D. in Molecular Biology and Biochemistry from Columbia University. She began her career as a legislative assistant for healthcare and technology at the US Senate and was a Congressional Science Fellow. She has over fifteen years of experience in finance and mergers and acquisitions.

In her last corporate position, Dr. Quraishi led the business development team for a GE Capital Company and was subsequently Commercial Quality Leader for GE Capital. In 2000, Dr. Quraishi was instrumental in the start-up and financing of Helicon Therapeutics, a genomics and drug discovery company focused on therapeutics for memory.

In the private equity arena, Dr. Quraishi was a Principal at Conning Capital Partners, a private equity firm and has served on several Boards. Dr. Quraishi also worked with the New York City Partnership and Investment Fund to prepare the first extensive study on the potential for development of biotechnology in New York City and prepared the report entitled "Market Demand Study for Commercial Biotechnology, Biomedical and Bioinformatics Facilities in New York City" with the Partnership.